Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?

PLoS Pathog. 2016 Nov 10;12(11):e1005938. doi: 10.1371/journal.ppat.1005938. eCollection 2016 Nov.

Authors

Karl Kuchler¹, Sabrina Jenull¹, Raju Shivarathri¹, Neeraj Chauhan^{2

3}

Affiliations

¹ Department of Medical Biochemistry, Medical University Vienna, Max F. Perutz Laboratories, Austria.
² Public Health Research Institute.
³ Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Animals
Antifungal Agents / therapeutic use*
Candida albicans / enzymology
Fungal Proteins / metabolism*
Histone Demethylases / metabolism*
Host-Pathogen Interactions / physiology
Humans
Lysine Acetyltransferases / metabolism*
Mycoses / metabolism*

Substances

Antifungal Agents
Fungal Proteins
Histone Demethylases
Lysine Acetyltransferases

Grants and funding

R01 AI124499/AI/NIAID NIH HHS/United States